Webster Bank’s Edwards Lifesciences EW Stock Holding History

Webster Bank’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-219	Closed	-$17.5K	–	714
2026 Q1	$17.5K	Hold	219	–	–	﹤0.01%	485
2025 Q4	$18.7K	Hold	219	–	–	﹤0.01%	455
2025 Q3	$17K	Sell	219 -420	-66%	-$32.8K	﹤0.01%	458
2025 Q2	$50K	Buy	639 +219	+52%	+$16.3K	0.01%	362
2025 Q1	$30.4K	Hold	420	–	–	﹤0.01%	400
2024 Q4	$31.1K	Hold	420	–	–	﹤0.01%	400
2024 Q3	$27.7K	Hold	420	–	–	﹤0.01%	410
2024 Q2	$38.8K	Buy	+420	New	+$37.2K	﹤0.01%	378
2023 Q2	–	Sell	-60	Closed	-$4.96K	–	561
2023 Q1	$4.96K	Hold	60	–	–	﹤0.01%	517
2022 Q4	$4K	Hold	60	–	–	﹤0.01%	502
2022 Q3	$5K	Hold	60	–	–	﹤0.01%	490
2022 Q2	$6K	Hold	60	–	–	﹤0.01%	485
2022 Q1	$7K	Hold	60	–	–	﹤0.01%	496
2021 Q4	$8K	Hold	60	–	–	﹤0.01%	500
2021 Q3	$7K	Hold	60	–	–	﹤0.01%	488
2021 Q2	$6K	Hold	60	–	–	﹤0.01%	484
2021 Q1	$5K	Hold	60	–	–	﹤0.01%	501
2020 Q4	$5K	Hold	60	–	–	﹤0.01%	490
2020 Q3	$5K	Hold	60	–	–	﹤0.01%	466
2020 Q2	$4K	Buy	+60	New	+$4.26K	﹤0.01%	473

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Webster Bank's EW Position: Q2 2026 in Review

Webster Bank sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 219 shares — an estimated $17.5K sold.

Webster Bank first reported a position in EW in Q2 2020 and held it in 20 quarters. The position peaked at $50K in Q2 2025. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Webster Bank reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
Webster Bank sold 219 Edwards Lifesciences shares in Q2 2026, an estimated $17.5K.
Webster Bank first reported a position in Edwards Lifesciences in Q2 2020 and held it in 20 quarters.
Webster Bank's Edwards Lifesciences position peaked at $50K in Q2 2025.
1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Webster Bank's 13F filing for Q2 2026, filed 20 Jul 2026.